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ABSTRACT 
Couples in HIV serodiscordant relationships frequently desire children. Although partners who 
are virally suppressed pose almost no risk of transmitting HIV to their partners, partners who 
are inconsistently on therapy may transmit HIV to their partners when attempting to conceive. 
Pre-exposure prophylaxis (PrEP) is an available safer conception strategy for these couples but 
is not consistently offered. We sought to better understand barriers to PrEP implementation for 
couples seeking conception and patient perceptions on what providers could do to encourage 
use. We conducted in-depth, qualitative interviews with 11 participants representing six 
couples taking PrEP for safer conception in a safety-net hospital in New England. Semi-
structured qualitative interviews assessed the following: Relationship nature and contextual 
factors; attitudes and perceptions regarding PrEP for safer conception; experience within health 
care systems related to HIV and PrEP; and facilitators, barriers, and other experiences using 
PrEP for safer conception. Four key themes have important implications for implementation 
of PrEP for safer conception:  Knowledge and understanding gaps regarding HIV and PrEP 
among both members of the couple, role of insurance and financing in decision-making, 
learning to manage and adhere to a treatment plan, and the need for providers to enhance 
knowledge and offer further support. Addressing barriers to safer conception strategies at 
multiple levels is needed to prevent HIV transmission within serodiscordant couples who 
desire children. Providers can play an important role in lowering these barriers through the use 
of multiple strategies.   
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INTRODUCTION 
With marked improvements in HIV treatment that have transformed HIV into a chronic, 
manageable illness, many HIV-infected individuals express similar life-goals as HIV-uninfected 
individuals, including desires to raise children (Deeks, Lewin & Havlir, 2013; Siegel, Meunier, 
Tocco & Lekas, 2017; Jones et al., 2016; Chen, Phillips, Knaouse, Collins & Miu, 2001). However, 
among couples with mixed HIV status, otherwise known as serodiscordant couples, conception 
and pregnancy can be a high-risk time for HIV transmission (Mugo et al., 2011). In serodiscordant 
couples where the female is HIV-infected and the male partner is uninfected, the risk of 
transmission can be mitigated through at-home insemination strategies (Zafer et al., 2016; Barnes 
et al., 2014; CDC, 2017).  However, couples comprised of an HIV-infected male and uninfected 
female require sperm wash techniques that remain costly, and few fertility clinics offer these 
specialized services, creating health disparities for serodiscordant couples wishing to conceive 
(ASRM 2015; Leech et al., 2018). Alternatively, serodiscordant couples may elect to conceive via 
condomless sex. While men who maintain an undetectable viral load pose almost no risk of 
transmitting HIV to their partners, women who cannot confirm their partner’s undetectable status 
remain at risk for HIV (CDC, 2017). Given that only 49% of the estimated 1.1 million people 
infected with HIV have achieved viral suppression, and that a high proportion of people living 
with HIV cycle in out of care and suppression (Yehia et al., 2015), many women in serodiscordant 
couples need additional HIV protection when attempting to conceive (CDC, 2017).  
Pre-exposure prophylaxis (PrEP), currently available as the medication Truvada®, and in 
a recently approved generic form, is a CDC recommended prevention strategy for women who 
cannot reliably confirm their partner’s HIV viral load but still desire children with their partners 
(Vernazza, Graf, Sonnenberg-Schawn, Geit & Meurer, 2011; Finocchario-Kessler et al., 2012; 
Heffron, Pintye, Matthews, Weber & Mugo, 2016; CDC, 2017; Center for Drug Evaluation and 
Research, 2017). Unfortunately, knowledge of PrEP among heterosexuals remains low, therefore 
many serodiscordant couples may not know to ask for PrEP (Walters et al., 2018). Additionally, 
PrEP adherence is critical to its efficacy. Although clinical trials have demonstrated the efficacy 
of PrEP for preventing sexually acquired HIV (Grant et al., 2010; Baeten et al., 2012; Thigpen et 
al., 2012; Karim, Kashuba, Werner & Karmin, 2011), adherence to daily oral regimens is required 
(Baeten et al., 2012, Amico et al,. 2013). In two large trials outside the US that failed to show 
efficacy of PrEP among women (FEM-PrEP and VOICE), less than 40% of participants were 
sufficiently adherent as measured by drug levels (Van Damme et al., 2012; Marrazzo et al., 2015).   
Health care providers can play an important role in encouraging PrEP uptake and 
adherence. For example, a study of serodiscordant couples in Kenya found that key factors in 
supporting PrEP initiation included confidence in medical providers and systems and perceived 
friendliness, support and empowerment from clinicians (Ngure et al., 2016). However, there are  
gaps in successful implementation of PrEP use for preconception in the US; a recent qualitative 
study of preconception counseling for couples in HIV serodiscordant relationships demonstrated 
that participants identified a lack of knowledge about safer conception strategies, limited access to 
providers knowledgeable about preconception counseling, received conflicting medical advice, 
and desired ongoing counseling and follow-up beyond what was routinely provided (Friedman, 
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Orlando, Anderson & Coleman, 2016). Therefore, the implementation of PrEP to prevent 
transmission in couples desiring conception warrants further exploration.  
Given the importance of practitioners and counseling in supporting serodiscordant couples’ 
PrEP uptake and adherence, we undertook a qualitative study of couples using PrEP for safer 
conception in an urban US medical center to better understand barriers to PrEP implementation 
and what patients believed providers could do to help support its use.  
 
METHODS 
Study Design and Participants  
We recruited Boston-based couples enrolled in an ongoing four-site pilot study of PrEP for 
safer conception for HIV-infected male and HIV-uninfected female couples (i.e., the PrEPception 
Study; Clinical Trials Identifier: NCT02233192).  All couples were taking PrEP for conception 
using a CDC protocol on clinical practice guidelines for PrEP for HIV-serodiscordant couples 
seeking conception (CDC, 2014). The protocol involves a detailed treatment plan including 
counseling on conception options, semen analysis for the HIV-infected male, regular 
documentation of HIV status, prescription of PrEP for HIV-uninfected women, combination anti-
retroviral therapy (cART) adherence for their HIV-infected male partners, and fertility tracking 
and timing of intercourse (i.e., limiting unprotected intercourse to periods of fertility and using 
condoms when not attempting to conceive).  The study also included baseline and one-year end-
point surveys of both partners, monthly PrEP adherence surveys with the females, and 
documentation of pregnancy outcomes. For the qualitative sub-study, we recruited 11 participants 
from six couples (five males, six females) enrolled at Boston Medical Center, a large urban safety-
net hospital. Participants provided written informed consent to participate; the Boston University 
Medical Center IRB approved all study activities.   
Instrument Development and Data Collection 
We developed semi-structured qualitative interview guides addressing the following 
domains of interest: 1) relationship nature and contextual factors; 2) attitudes and perceptions 
regarding PrEP for conception; 3) experience with the health care system related to HIV and PrEP; 
and 4) facilitators and barriers to the use of PrEP for conception.  A trained qualitative interviewer 
with experience in the PrEPception Study protocol conducted in-depth, individual interviews with 
participants between September 2015 and January 2016. If both partners agreed to participate, we 
interviewed female and male partners at different times. We digitally recorded all interviews, 
which lasted between 19 and 59 minutes, with a mean of 42 minutes.  
Data Analysis   
A professional transcription company transcribed the audio recordings verbatim; the 
written transcripts were reviewed for accuracy of transcription.  To conduct the analysis, standard 
qualitative methods including the basic procedures of grounded theory and constant comparative 
methodology (Pope, Zibland & Mays, 2000; Glaser and Strauss, 1967) were used. Analyses 
involved multiple rounds of coding and analysis. First, two researchers independently reviewed 
two transcripts to identify potential codes; the entire research team then met to discuss these 
potential codes and develop an initial coding scheme. This initial coding scheme included eight 
primary codes; these included financial considerations, fertility issues and decisions, normalcy, 
health beliefs and knowledge, PrEP decision making, social context, experiences using PrEP, 
culture and 17 sub-codes that further detailed the larger codes. Second, three members of the 
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research team independently coded two different transcripts using the initial coding scheme and 
noted any new observations or inadequacies of the coding scheme.  The entire research team then 
met to discuss preliminary findings from this round of coding and ways to revise the initial coding 
scheme to allow for a better ‘‘fit’’ of existing codes to the new data. During this discussion, team 
members proposed new codes and subcodes where needed. The entire team discussed these code 
revisions until they reached consensus (i.e., agreement regarding code definitions and application), 
resulting in a final coding scheme. The final coding scheme included 15 primary codes and 14 
subcodes. Relevant codes for this analysis included counseling, finances, health 
knowledge/beliefs, HIV (in general), PrEP decisions, PrEP knowledge and beliefs, PrEP 
use/experience, and recommendations for services. Finally, the team members applied the final 
coding scheme to the remaining transcripts using the qualitative software package NVivo, which 
also helped with data management and organization. The most frequently applied codes included 
HIV (in general) (95), PrEP use/experience (66), PrEP knowledge and beliefs (48), and counseling 
(42). After all coding was completed in NVivo, analyses was conducted by the entire research 
team and involved synthesizing coded data, identifying key emergent themes and connections 
between themes, and comparing themes across participants. Representative quotes to illustrate key 
themes were selected and presented below using pseudonyms to protect confidentiality.   
 
RESULTS 
Participant Characteristics 
Table 1 describes characteristics of the study participants.   
Table 1. Characteristics of Qualitative Study Participants – Six Couples (n=11)* 
Variable Male (n=5) Female (n=6) Total (n=11) 
 N      (%) N      (%) N      (%) 
Median age (Q1, Q3) 39 (36-48) 35.5 (30-41) 37 (34-44) 
Black Race  5 (100) 6 (100) 11 (100) 
Hispanic/Latino 2 (40) 0 (0)   2 (18) 
Born outside US 4 (80) 3 (50)   7 (64) 
Currently employed 3 (60) 6 (100)   9 (82) 
Health insurance 
    Commercial 3 (60) 4 (67)   7 (64) 
   Medicaid 2 (40) 2 (33)   4 (36) 
Highest level of education completed:  
     High school  3 (60) 1 (17)   4 (36) 
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     Some college 1 (20) 2 (33)   3 (27) 
      College 1 (20) 3 (50)   4 (36) 
Attend religious services >weekly 4 (80) 5 (83)   9 (82) 
Married 3 (60) 4 (67)   7 (64) 
Has children  
  
4 (80) 
 
2 (33)   6 (55) 
Children with current partner  1 (20) 1 (17)   2 (18) 
Previous fertility treatment/safer 
conception attempts  
NA 3 (50%)   NA 
* 1 male partner declined participation 
Core Themes 
In interviews, participants described their experiences and those of their partners including 
challenges relating to desires to conceive, learning about PrEP as an option for safer conception, 
and PrEP experiences.  The data revealed four key themes with important implications for the 
implementation of PrEP for safer conception: 1) gaps in knowledge about HIV and PrEP among 
both partners; 2) role of insurance and financing in decision-making; 3) importance of learning to 
manage and adhere to a treatment plan; and 4) desire for providers to create support structures 
related to HIV and conception. Our findings in each of these domains are described below.   
Knowledge Gaps.  A striking finding was the extent to which participants of both sexes 
held misperceptions about HIV and PrEP, even following education and counseling by health care 
providers as a prerequisite to starting PrEP.  Participants indicated confusion in many areas, 
including disbelief that they or their partner had HIV, what an undetectable or low viral load meant, 
whether or not there was a cure for HIV, and how HIV is transmitted. Many of these beliefs were 
rooted in confusion from past or current partners not contracting HIV, which reduced their 
perceived need for PrEP. Some women expressed skepticism that their partners were HIV positive 
because they had not become infected with HIV.  For example, female participant Efie stated ‘I 
don’t believe my husband is HIV positive’ because prior to starting PrEP they had unprotected sex 
and she had not contracted HIV. Others believed that HIV was curable.  Female participant Amaka 
declared ‘I look at HIV as any other disease...you treat it and it goes away.’  Some men also 
expressed confusion or disbelief about their HIV status, explaining that their low viral loads meant 
they did not have the infection or, if they were infected, they would not be able to transmit it.  For 
example, male participant Oko expressed disbelief saying, ‘Me, personally…I don’t believe it.  
Because…back home all my previous women, they are all living healthy, nobody even have that 
kind of disease.’ 
A final misconception was the belief that PrEP was a fertility treatment rather than an HIV 
prevention method.  This misunderstanding was primarily expressed when participants addressed 
the role of financing and insurance in decision making about PrEP, as described below.   
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Role of Insurance and Financing in PrEP Decision-Making.  All participants discussed 
experiencing financial stress, which was a core component of their decision-making surrounding 
conception options.  Insurance often covered PrEP, but many insurers, including Medicaid, would 
not cover fertility treatment, making it prohibitively expensive.  Even if fertility treatment was 
covered, there were other barriers such as a requirement to try natural conception for an extended 
period prior to coverage beginning. Additionally, most couples did not have difficulty conceiving 
and did not require fertility techniques to conceive, but considered assistive reproductive 
technology to conceive safely.   Thus, PrEP ended up being a financially feasible option.  A 
common sentiment was that PrEP was a more practical choice that was covered by their insurance.  
Female participant Mutesi said,  
‘She [the physician] also talked about the IUI [intrauterine insemination], the IUI and the 
IVF [in vitro fertilization]… the insurance I had would not cover it.’ 
 Male participant Oko said, ‘Because the sperm (wash) was -I think you have to spend a lot of 
money on that I think.’  Female participant Efie had previously tried assisted reproduction and 
described the financial barriers that she and her partner experienced:  
‘In fact it was a big problem. A whole lot of challenges. So it came to a point that we told 
them we are no longer interested. Because we have to be paying for the storage fee every 
month.’  
PrEP was also viewed as more convenient than fertility treatments, which were perceived as 
requiring more visits, traveling greater distances to appointments, and demanding time off from 
work, which was challenging for these couples of limited means.  Male participant Jean Caleb said  
‘It’s easier because, she’s worried about her job and she take her off time to come here, 
and to keep comin’ and even the appointment to follow the appointment with the doctor, 
and that will be like I said, that will be more, so, us, if we can come here once that will be 
very helpful for her’  
His partner Nina agreed, stating: ‘At the time I think it [insemination] was the only option that 
worked for us, whereas with PrEP…it's actually a lot more convenient.’ 
Learning to Manage and Adhere to a Treatment Plan.  Many participants spoke about the 
importance of managing and adhering to their treatment plan, viewing this as a joint (couple) 
activity, responsibility, and challenge. For some participants, the fact that both members of the 
couple had to adhere to a medication regimen (the male to cART and the female to PrEP) meant 
that they could do it together, making it seem easier.  Isaiah, who understood the importance of 
PrEP for safe conception, stated, 
‘To keep us safe is my main priority, to keep the baby safe is my main priority…We take 
our medication together every day…Just take it like it’s a vitamin.’ 
 Several male partners said they helped remind their female partners to take PrEP because they 
were more accustomed to taking HIV medication daily; several of the women also stated that their 
partners would remind them to take PrEP when they were taking their HIV medication.  Because 
viral load suppression among the HIV-infected male partners was a clinical requirement for 
prescribing PrEP for conception to the females, the HIV-infected men in the sample were adherent 
to medication.  These men described themselves, and were described by their female partners, as 
strongly supportive of adherence. Female participant Amaka stated,  
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‘He bought me a little container to put my medication in to always remember to take it at 
work…he’s been supporting me to make sure that I take my medication every day because 
I tend to forget at times.’  
In addition to male partner support, several women also described their own strategies for 
adherence.  Female participant Nina, who initially thought that it might be challenging to take her 
pill every day, said she quickly learned to adhere because she understood the ramifications of not 
being adherent:  
‘It required my being very committed to taking the medication on time, every time…For 
me that is a challenge, because I'm just not a medication person at all. Like I don’t do birth 
control, so it was a challenge for me, but obviously when you know the consequences could 
be so serious, you kind of get into the habit pretty quickly.’ 
For the women who did find adherence difficult, it was due to ‘just remembering’ because they 
were ‘not used to dealing with stuff like that’ and tended to forget with their busy schedules. 
Another obstacle to treatment management and adherence was learning manage PrEP side effects 
(actual or anticipated).  Some women spoke of having headaches, dizziness, drowsiness, 
stomachaches, and female participant Efie complained of ‘being forced to eat because of the 
medication.’ Male partners were also a source of support while working through side effects or 
fear of side effects from the medication. Male participant Isaiah described how he tried to reassure 
his female partner after the doctor told her she might experience side effects, stating: 
‘You might go through some discomfort, or [something] like that…Don’t think about none 
of that, [I told her], just think about it as a vitamin… if your mind is paranoid…you’ll be 
that one percent that goes through all the bad side effects.’  
Need for Increasing Support.  Many participants spoke about the importance of obtaining 
more support and wondered if their providers could assist in that arena. Their prior limited 
awareness about PrEP and safer conception options led to fear and isolation that they hoped could 
be ameliorated for others.  They suggested addressing this by ensuring that more providers knew 
about PrEP and offered it to patients.  Female participant Hailey described how awareness could 
be improved via providers: 
‘I’m surprised that nobody knows about Truvada.  And it’s like why not spread that?  Why 
not tell everybody that?  Because that solves a lot of isolation.  It solves a lot of problems.’  
 Participants also desired support from other serodiscordant couples who had used PrEP for 
conception.  They believed that while they were considering all their options for safer conception, 
it would have been extremely helpful for them to hear about the experience of taking PrEP for 
conception directly from couples who have experienced it and hoped that their providers would 
set up these networks.  Female participants were particularly interested in having contact with and 
support from other women who would understand what they were going through and felt that 
health care providers could play a role in identifying other couples.  As stated by female participant 
Amaka: 
‘I would encourage if you could bring in couples who have used the PrEP to really try to 
talk to, the couples who are trying to go into it. Because like myself when… I started it, and 
I was like okay, and my husband has told me all of this information.  It’s true, but I don’t 
believe him.  So, he…brought me to his doctor, and the doctor told me…But-if there was a 
person like me and my husband and we come face-to-face, and we tell this person like, you 
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know, “It’s true, it has worked for me.”  I believe it could be couples out there who are 
willing to come up and help other couples.’ 
 
DISCUSSION 
Our results provide important information to consider when planning the implementation 
of PrEP for safer conception in the US.  The four core themes identified have important 
implications for clinical practice and counseling processes.   
First, participants held misconceptions about both HIV and PrEP. Participants learned 
about PrEP through their HIV providers and had received standard patient education about HIV 
from those providers. Yet, despite ongoing counseling, interviews with both male and female 
participants suggested a limited understanding about some facets of HIV and PrEP.  As English 
was a second language for some participants, misunderstanding may have stemmed from language 
and health literacy barriers, as found in other studies of HIV (Murphy et al., 2010) and other 
diseases (Flores, 2006; David and Rhee 1998).   
Second, financial stress was a major barrier to conception, and prior to the study, most 
couples were unaware of PrEP as an alternative risk reduction option to assisted reproductive 
technologies. Participants also described logistical and accessibility barriers to fertility treatment, 
which is unsurprising given the high cost and limited insurance coverage of fertility treatment in 
addition to accessibility challenges for HIV-positive individuals (Friedman et al., 2016; Sauer, 
2006; ASRM, 2015).  In addition, given the importance of how couples considered PrEP to be a 
more “natural” conception option (Bazzi, Leech, Biancarelli, Sullivan & Drainoni, 2017), PrEP is 
likely to be a highly promising, acceptable and affordable option for this population. As HIV is 
known to affect those with lower socioeconomic status, PrEP could potentially aid in closing this 
disparity in access for serodiscordant couples and safe conception care (Rubin, Colen & Link, 
2010; Newmeyer et al., 2011). 
Third, adherence was described as challenging for individuals not used to taking daily 
medications. This reflects findings from other studies on a range of health conditions (Ho, Bryson 
& Rumsfled, 2009; Jones, Butler, Thomas, Peveler & Prevett 2006; Sabaté, 2003) showing that 
adherence may be particularly challenging for individuals who are not feeling ill or have 
conflictual feelings about taking medications due to concerns about possible side effects.   
Finally, participants were vocal about the need for additional support and saw an important 
role for providers in this area.  Participants believed that having connections to and support from 
other couples who were experienced with safer conception could help with adherence and 
treatment management.  The value of peer support and education has been shown in a range of 
fields, including HIV interventions (Garfein et al., 2007; Wolitski, Gomez & Parsons, 2005).   
Based on these core themes, we suggest the following specific strategies.  Efforts are 
needed to enhance education, both for providers and members of serodiscordant couples, 
especially in light of the changing CDC guidelines in 2017. While the CDC no longer recommends 
PrEP for serodiscordant couples in which the HIV-infected partner is virally suppressed, PrEP is 
an important HIV prevention method for couples in which this is not the case (CDC, 2017). Since 
many people living with HIV cycle in and out of care, and thus maintain inconsistent suppression 
levels (Yehia et al., 2015), it is critical to increase providers’ knowledge of PrEP and when it 
should be prescribed. Although HIV providers are more experienced with these issues, they are 
unlikely to see HIV-negative persons (Krakower, Ware, Mitty, Maloney & Mayer, 2014); women 
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desiring conception are most likely to be seen by primary care or women’s health providers.  
Studies indicate that primary care providers are not likely to discuss sexuality issues with patients 
(Drainoni, Dekker, Lee, Boehmer & Relf, 2009) and have limited knowledge and experience 
prescribing PrEP (Arnold et al., 2012). We recommend that providers seeing uninfected partners 
collaborate with HIV providers treating infected partners of serodiscordant couples to establish 
networks for their own education and better support PrEP implementation.   
All providers, but particularly those who work with women hoping to become pregnant, 
would be well-served to learn about the partners of those women.  Studies have shown that strong 
patient-provider relationships contribute to better adherence and health outcomes among persons 
living with HIV (Beach, Keruly & Moore, 2006; Roberts, 2002). Accurate consumer knowledge 
has also been shown to be an important first step in the implementation of PrEP (Liu et al., 2014). 
Ideally, providers working with serodiscordant couples should establish strong relationships with 
both partners and provide HIV education to the couple together. It is critical to ensure that both 
partners understand what HIV means for the couple, how it affects children and transmission risks, 
while also addressing any misunderstandings. Providers should further explain how PrEP and other 
options for safe conception work and help troubleshoot coverage and financing issues for different 
safe conception options. These efforts could be informed by and adapted from similar models for 
couples counseling that have been proven effective in reducing HIV risks (Farquhar et al., 2004; 
Rosenberg et al., 2013; Sullivan et al., 2014).   
Yet, joint counseling may not be enough or possible. Couples in our study still exhibited 
misconceptions and confusion about fertility treatments and safer conception after frequent joint 
counseling by two providers with strong knowledge and interest in PrEP. Utilizing additional 
counseling strategies such as the teach-back method, which has been recommended for improving 
low health literacy (Kountz, 2009) would be useful in ensuring the level of understanding 
necessary for adequate uptake of and adherence to PrEP.  Additionally, although not necessarily 
the purview of individual providers, the education-understanding disconnect that we found 
highlights the need for careful design, piloting, evaluating, and disseminating effective education 
techniques. This need may be particularly critical for the topic of PrEP for safe conception, which 
involves concepts of horizontal (male to female partner) and vertical (mother to baby) transmission 
and communication regarding sophisticated medical innovations.  Our findings point to a 
potentially fatal gap at the beginning of the “HIV prevention continuum”: a lack of effective 
education about the basic concepts of HIV transmission, safer conception, and prevention options.  
Failure to educate patients in such early parts of this continuum could render it increasingly 
difficult to provide effective education later on regarding the importance of adherence or following 
other specific areas of safe conception treatment plans.  
However, we acknowledge potential barriers to achieving high patient comprehension 
through joint couple counseling.  First, HIV-infected men have been found to desire reproductive 
health services but also to face barriers to access (Khidir et al., 2017) In many cases, both partners 
are unlikely or unable to be seen in the same practice setting.  Although, like teach-back, skills 
building can be integrated into ongoing couples’ counseling and could be based on the 
Information-Motivation-Behavioral Skills model, which has been shown effective in chronic 
disease self-management including adherence to HIV treatment regimens (Fisher, Fisher, Amico 
& Harman, 2006; Gifford and Groessl, 2002) counseling is time consuming and poorly reimbursed 
by insurance.  Even if a provider is willing to provide such counseling, it may be impossible to do 
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within the confines of a 20-minute clinical visit. Thus, providers need to consider novel and 
potentially more feasible education methods involving other teaching strategies and other members 
of care teams, such as patient navigators or nursing staff. Additionally, appreciating that providers 
may not have access to both members of the couple, it is critical that the female partner understand 
both her own and her partner’s role in HIV prevention during conception. While cART is an 
effective form of HIV prevention (CDC, 2017), providers should stress that utilizing PrEP can act 
as an additional layer of protection that female participants have direct control over, which one 
recent pilot found was desired by serodiscordant couples and may be considered empowering for 
these women (Loufty et al., 2017). Especially in cases when the HIV-negative partner cannot 
confirm their partners’ suppression levels and may not be in a position to negotiate this, PrEP 
offers a valuable prevention tool. 
While some strategies will require larger infrastructure and organizational shifts, efforts to 
improve patient education about PrEP, couple-counseling for safe conception, and couple-provider 
relationships should be feasible for providers working within current systems. At the individual 
patient and larger contextual levels, there are available strategies to increase engagement that 
should be relatively simple to employ, such as the core activities of education, skill building and 
relationship building, by the clinician.  Identifying methods to use other members of care teams to 
engage in skills-building and couples’ counseling will be essential to fully operationalize these 
goals.  
This study has limitations. First, participants received their services in one institution in 
Massachusetts; therefore, their views might not generalize to other similar couples desiring 
conception.  However, given the health care environment in Massachusetts, we anticipate that 
barriers could be even greater in other settings characterized by lower awareness of PrEP and 
support through public insurance systems. Second, as in any qualitative study, although 
participants were assured of confidentiality and their responses appeared to be candid, we cannot 
exclude the possibility of biased or socially desirable responses. Nevertheless, we sought to 
examine participants’ experiences in order to help address PrEP implementation issues, and we 
believe that our findings have important implications for clinical practice, patient education, and 
patient-provider communication. 
 
CONCLUSION 
Although barriers to accessing safe conception strategies involving PrEP exist for HIV 
serodiscordant couples at the individual, couple, system, and societal levels, there are multiple 
strategies that could be implemented to lower these barriers. The financial feasibility of PrEP and 
its potential role as an empowerment tool for safer conception could potentially decrease 
disparities for serodiscordant couples who wish to conceive. Additionally, while we focused on 
PrEP for safe conception among HIV serodiscordant couples, much of what we learned is broadly 
applicable to implementation of provider and health care interventions for a range of chronic and 
stigmatized health conditions.  
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